Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Arteriolar hyalinization in implantation kidney biopsy as predictor of the graft function

E Ważna, J Pazik, Z Lewandowski, A Perkowska-Ptasińska, S Nazarewski, A Chmura, M Durlik

Ann Transplant 2009; 14(1): 22-22 :: ID: 880279

Abstract

Background: Many factors influence long-term function of transplanted kidney. Increasing number of evidences support the fact that histological assessment of implantation kidney biopsies can predict short- and long-term graft survival. Objective: Kidney function evaluation 2 years after transplantation depends on implantation chronic abnormalities present in donor's biopsy.
Material/Methods: Inclusion criteria: engraftment between 2006-2007 and serum creatinine concentration 1-2 mg/dl at 3 months after transplantation. By chronic abnormalities present in the donors' biopsy were understood arteriolar hyalinization (ah), interstitial fibrosis (ci), sclerotisation of the intimae (cv), tubular atrophy (ct), total inflammation (ti) and sclerotic glomeruli (Banff 2004). Graft function 2 years after engraftment was evaluated by eGFR C&G and serum creatinine concentration. Median observation time was 24.4 (15-32) months. Statistical analysis was performed using GLM Procedure of SAS System.
Results: Baseline transplant function (3 months after transplantation) was  similar in groups with and without chronic abnormalities. In the group with at least one abnormality in comparison to the group without abnormalities in biopsy (24 vs. 14) similar graft function after two years was found. However, graft function was significantly diminished in individuals with graft affected by arteriolar hyalinization (ah) compared to recipients free from ah (16 vs. 36) (mean eGFR values: 51.2±14.8 and 62.0±16.7, respectively - p <0.03, serum creatinine concentrations were 1.76±0.36 and 1.51±0.48 mg/dl, respectively - p<0.09).
Conclusions: The only predictor of graft function at 2 years was ah type abnormalities at implantation. This finding should be considered while choosing immunosuppressive regimen.

Keywords: Kidney Transplantation

Add Comment 0 Comments

In Press

Original article  

Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...

Ann Transplant In Press; DOI: 10.12659/AOT.951568  

Original article  

Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.950589  

Database Analysis  

Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...

Ann Transplant In Press; DOI: 10.12659/AOT.950289  

Original article  

Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...

Ann Transplant In Press; DOI: 10.12659/AOT.950997  

Most Viewed Current Articles

24 Aug 2021 : Review article   18,372

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

05 Apr 2022 : Original article   14,731

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

22 Nov 2022 : Original article   14,244

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

29 Dec 2021 : Original article   13,752

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358